Geneva, Oct. 8 -- International Clinical Trials Registry received information related to the study (ISRCTN18363197) titled 'Changes in stress hormones in patients with treatment-resistant depression treated with ketamine' on Sept. 25.
Study Type: Observational
Study Design:
Open naturalistic prospective longitudinal observational study (Treatment)
Primary Sponsor: Department of Psychiatry of Faculty of Medicine, Comenius University and University Hospital Bratislava
Condition:
Response to ketamine in patients with treatment-resistant depression
Mental and Behavioural Disorders
Intervention:
All participants will receive intravenous ketamine as part of standard clinical treatment for treatment-resistant depression (TRD), administe...